Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors

Clinical trial NCT03074513 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03074513
Sponsor: M.D. Anderson Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Appendix Adenocarcinoma Human Papillomavirus-Related Anal Squamous Cell Carcinoma Human Papillomavirus-Related Cervical Squamous Cell Carcinoma Human Papillomavirus-Related Squamous Cell Carcinoma of the Penis Human Papillomavirus-Related Vulvar Squamous Cell Carcinoma Neuroendocrine Carcinoma Pancreatic Neuroendocrine Tumor Recurrent Merkel Cell Carcinoma Recurrent Nasopharynx Carcinoma Recurrent Peritoneal Malignant Mesothelioma Recurrent Pleural Malignant Mesothelioma Stage III Merkel Cell Carcinoma AJCC v7

Start date: 2017-03-03
Primary completion: 2027-09-30
Enrollment: 133

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.